Endotracheal Tube Market

Endotracheal Tube Market Size, Market Forecast and Outlook By FMI

Summary of the Endotracheal Tube Market

• Demand and Growth Drivers
  • ICU capacity expansion and post-pandemic hospital investment are likely to support strong demand as hospitals across North America, Europe, and Asia-Pacific continue expanding ventilator inventory and critical care infrastructure.
  • Infection control protocols and single-use device standardization are likely to remain a key growth driver as hospitals increasingly adopt disposable endotracheal tubes with subglottic suction ports and antimicrobial coatings to reduce ventilator-associated pneumonia risks.
  • Aging population growth and rising chronic respiratory disease prevalence are expected to support adoption as COPD, ARDS, and post-surgical respiratory complications continue increasing the need for emergency and elective intubation procedures during the forecast period.
• Product and Segment View
  • Regular Endotracheal Tube is likely to remain the leading product segment, supported by strong use across routine airway management, ICU ventilation, and emergency treatment procedures.
  • Orotracheal is likely to lead the route type segment, driven by its widespread use in emergency intubation, ICU ventilation, and surgical anesthesia applications.
  • Emergency Treatment is likely to remain an important high-value application segment as hospitals prioritize rapid airway management for trauma, respiratory failure, and critical care admissions.
• Geography and Competitive Outlook
  • The United States is likely to remain a key market owing to strong ICU infrastructure, high hospital procurement volumes, and sustained post-pandemic investment in respiratory care capacity.
  • South Korea is likely to sustain strong demand due to advanced hospital systems, aging demographics, and increasing focus on infection control and critical care management.
  • Companies that can combine infection-control innovation, hospital procurement access, and large-scale manufacturing capabilities are likely to gain traction during the forecast period.
• Analyst Opinion
  • Nandini Roy Choudhury, Principal Consultant at FMI says, “Companies that can improve infection-control performance, support ICU standardization, and align with hospital procurement requirements are likely to strengthen their position over the forecast period.”
  • The endotracheal tube market is evolving from a standard airway management category into a more specialized infection-control and critical care segment.
  • Adoption is being driven by strong demand for disposable, single-use devices that improve patient safety and reduce hospital-acquired infection risks.
  • The market is also benefiting from expanding ICU capacity and the growing burden of chronic respiratory diseases across aging populations.
  • Demand is further supported by the need for cost-efficient airway management solutions that balance performance, compliance, and long-term hospital care outcomes.

Key Takeaways

• The endotracheal tube market was valued at USD 2.62 billion in 2025.
• By 2036, the endotracheal tube market is expected to be worth USD 5.14 billion.
• From 2026 to 2036, the market is projected to expand at a CAGR of 6.3%.
• The market is projected to create an incremental opportunity of USD 2.35 billion between 2026 and 2036.
• In 2026, regular endotracheal tubes are expected to account for 35.6% of the product type segment, driven by sustained hospital demand and emergency airway management requirements.
• The United States (6.50%) and South Korea (6.40%) are two of the fastest growing markets in the world.

Endotracheal Tube Market Definition

The endotracheal tube market covers single-use and reusable endotracheal tubes including regular, reinforced, preformed, double-lumen, and cuffed and uncuffed configurations made from polyvinyl chloride, silicone, thermoplastic elastomer, and specialty polymer materials used in emergency airway management, general anesthesia, and intensive care ventilation across hospitals, clinics, ambulatory surgical centers, and emergency medical services.

Endotracheal Tube Market Inclusions

Market scope includes all commercially traded products in the endotracheal tube market segmented by product type (Regular Endotracheal Tube and peer options), route type (Orotracheal and peer options), application, and end use (Hospitals and peer channels). Revenue sizing spans the 2026 to 2036 forecast period.

Endotracheal Tube Market Exclusions

The scope excludes tracheostomy tubes used for long-term airway management, laryngeal mask airways and supraglottic devices, flexible fiberoptic bronchoscopes, industrial rubber and polymer tubing for non-medical applications, and veterinary endotracheal tubes used in animal anesthesia.

Endotracheal Tube Market Research Methodology

• Primary Research: FMI analysts conducted interviews with procurement leads, category managers, and product development heads at manufacturers, distributors, and buyer accounts in the endotracheal tube market across North America, Europe, and Asia-Pacific.
• Desk Research: To set verifiable baseline parameters, we gathered statistics from industry associations, regulatory filings, company annual reports, and trade publications.
• Market Sizing and Forecasting: To get baseline values for the endotracheal tube market, we add up the number of transactions from the bottom up and use region-specific growth rates and substitution curves to predict demand through 2036.
• Data validation and update cycle: Every three months, projections are checked against customer survey data, manufacturer shipment reports, and regulatory filings.

Why is the Endotracheal Tube Market Growing?

• Volume expansion is running on two parallel tracks: structural end-user demand in the critical care medical devices and respiratory care sector and product innovation extending applications across adjacent use cases.
• Infection Control and Single-Use Device Standardization is generating reformulation and investment cycles, reshaping the margin pool across commodity and premium tiers.
• Aging Population and Chronic Respiratory Disease Growth is compressing timelines for competitive response, favouring scaled manufacturers with capital access over fragmented regional players.

The endotracheal tube market is growing steadily. This is due to structural demand in the critical care medical devices and respiratory care sectors, new products and formats, and the pressure on commodity players to reformulate for premium positioning. Post-pandemic hospital ICU capacity growth in the US, Germany, the UK, Japan, and South Korea has influenced demand. The growth of ventilator inventory and ICU beds from 2020 to 2024 keeps hospitals buying single-use endotracheal tubes on a regular basis. Hospital GPO contracts drive multi-year volume commitments.

The standardization of single-use devices and infection control is adding a new layer of growth. Growth is due to hospital-acquired pneumonia prevention programs that require endotracheal tubes with subglottic suction ports, silver-coated surfaces, and antimicrobial polymer formulations. Medtronic, Teleflex, and Smiths Medical put money into high-end products that cost a lot more than regular PVC tubes.

The growth of chronic respiratory disease and the aging population are both things that drive growth and put pressure on margins. Adoption is growing because older people in developed markets are being admitted to the ICU for COPD flare-ups, ARDS, and respiratory problems after surgery. There is more demand in Asia-Pacific markets like China, South Korea, and Japan because hospitals are getting bigger and there are more elderly patients.

Segmental Analysis

• Regular Endotracheal Tube will hold 35.6% of the market share for its type in 2026. This is because it has strong relationships with buyers and is well-known in the format.
• Orotracheal (61.7%) and Emergency Treatment (48.3%) show that core usage patterns are the main drivers of volume.
• Hospitals have a 57.2% share, but adjacent channels are shortening order lead times and making it easier for mid-size buyers to get to their accounts.

There are different types of endotracheal tubes, routes, applications, end uses, and geographic regions. The market is split into two groups based on the type of product: Regular Endotracheal Tube and peer categories. There are two types of routes in the market: Orotracheal and peer formats. The market is divided into Emergency Treatment and related options based on how they are used.

Insights into the Regular Endotracheal Tube Segment

The Regular Endotracheal Tube is expected to have the biggest share of the product type segment in 2026, with 35.6%. This leadership is based on what customers want, how well the product works for the main use cases in the category, and how well it competes with other products.

In the regular endotracheal tube category, premium sub-formats are becoming more popular as buyers respond to needs for quality, bioavailability, or regulatory positioning. Changing buyer preferences and reformulation in response to compliance pressure are driving the fastest-growing sub-segment.

Even though there are new competitors in similar formats, regular endotracheal tubes are expected to keep most of the market share through 2036. This is because other categories are having a hard time matching the price, performance, and supply reliability that the core buyer base needs.

Insights into the Orotracheal Segment

In 2026, Orotracheal is expected to make up 61.7% of the route type segment. This format is the most popular because it's easy to handle, it's cost-effective to distribute, and it works with the biggest buyer groups in the endotracheal tube market.

The orotracheal format is growing in new markets like China, India, and Southeast Asia, which is driving demand at above-average rates. In mature markets, steady per-capita consumption and reformulation cycles keep replacement volume steady.

Endotracheal Tube Market Drivers, Restraints, and Opportunities

• ICU Capacity Build-Out and Ventilator Utilization Growth are driving up demand for higher-specification product designs and higher prices.
• The aging population and the rise of chronic respiratory diseases are making reformulation investments necessary, which is hard on smaller manufacturers but good for larger ones.
• Emerging Market Hospital Infrastructure and Single-Use Transition is closing the performance gap with older categories, moving premium formats from niche positioning to mainstream specification.

The endotracheal tube market is growing steadily because more people are using ventilators and more people are getting chronic respiratory diseases as they get older. This is because more people are getting chronic respiratory diseases and more people are getting older. In response, manufacturers are creating new product formats and business models that meet changing consumer and regulatory needs. There are big chances for growth in specialty formats, expanding into new markets, and coming up with new premium-tier products, even though there are problems like the cost of raw materials going up and down, the need to invest in tools, and rules that change.

ICU Capacity Build-Out and Ventilator Utilization Growth

The expansion of hospital ICU capacity in the United States, Germany, the UK, Japan, and South Korea following the pandemic has shaped demand. The growth of ventilator inventory and the addition of ICU beds from 2020 to 2024 mean that hospitals will keep buying single-use endotracheal tubes. Hospital GPO contracts drive multi-year volume commitments.

VAP Prevention and Subglottic Suction Port Specification

Growth is due to hospital-acquired pneumonia prevention programs that are pushing for endotracheal tubes with subglottic suction ports, silver-coated surfaces, and antimicrobial polymer formulations. Medtronic, Teleflex, and Smiths Medical put money into high-end products that cost a lot more than regular PVC tubes.

Aging Demographics and Chronic Respiratory Disease Expansion

Adoption is growing because older people in developed markets are going to the ICU more often for COPD flare-ups, ARDS, and breathing problems after surgery. The Asia-Pacific markets, which include China, South Korea, and Japan, are seeing more demand because hospitals are getting bigger and more elderly patients.

Emerging Market Hospital Infrastructure and Single-Use Transition

Investment in hospital infrastructure in India, Southeast Asia, and Latin America, along with WHO-backed programs to standardize single-use devices, is changing the way growth happens. To meet the growing demand for goods in emerging markets, local manufacturers and multinational distributors are creating regional supply chains.

Analysis of Endotracheal Tube Market By Key Countries

Country	CAGR
United States	6.50%
South Korea	6.40%
European Union	6.30%
United Kingdom	6.20%
Japan	6.20%

• North America and Western Europe are mature regions where growth reflects format transition and premium positioning rather than pure volume expansion, while Asia-Pacific represents the highest absolute growth from rising consumer penetration and organized distribution expansion.
• The United States leads the tracked country roster at 6.50% CAGR, shaped by post-pandemic ICU capacity expansion, VAP prevention program investment, and hospital GPO contract procurement through Vizient, Premier, and HealthTrust.
• China and India are emerging as fast-growing national markets, propelled by organized-retail expansion, rising consumer awareness, and regulatory alignment with global product standards.
• Middle East and Africa remain early-stage, with GCC hospitality, healthcare, and organized retail infrastructure investment creating the initial demand base for certified and branded supply.

The endotracheal tube market is projected to grow globally at a CAGR of 6.3% from 2026 to 2036. Among the top markets, the United States leads at 6.50%, followed by South Korea at 6.40%, followed by European Union at 6.30%, followed by United Kingdom at 6.20%, while Japan posts 6.20%. The analysis spans over 30 countries, with the leading markets detailed below.

Demand Outlook for Endotracheal Tube Market in United States

The United States is projected to grow at a CAGR of 6.50% through 2036, shaped by post-pandemic ICU capacity expansion, VAP prevention program investment, and hospital GPO contract procurement through Vizient, Premier, and HealthTrust. Medtronic (Shiley), Teleflex Incorporated, and Smiths Medical dominate US endotracheal tube distribution, with BD, ConvaTec, and Mercury Medical competing in hospital GPO and specialty segments.

• Post-pandemic ICU capacity expansion sustains recurring category demand.
• Leading national operators invest in premium format capacity and branded positioning.
• Direct-to-consumer and specialty retail channels expand alongside traditional distribution.

Future Outlook for Endotracheal Tube Market in United Kingdom

The United Kingdom is projected to grow at a CAGR of 6.20% through 2036, with demand supported by NHS hospital procurement frameworks, rising ICU capacity following COVID-era expansion, and single-use device standardization protocols. Medtronic UK, Teleflex, and Smiths Medical lead NHS procurement, with Venner Medical and specialty distributors serving independent healthcare providers.

• NHS hospital procurement frameworks sustains category volumes.
• Pharmacy and specialty retail chains concentrate branded distribution.
• E-commerce and DTC subscription platforms expand consumer reach.

Opportunity Analysis of Endotracheal Tube Market in Germany

Germany demonstrates steady growth through 2036 as the country's buyer base responds to DRG reimbursement frameworks supporting premium single-use device adoption, strong ICU infrastructure, and European CE marking standardization. Medtronic Germany, Teleflex GmbH, and Smiths Medical lead the German market, with Draeger Medical supplying specialty respiratory device category adjacencies.

• DRG reimbursement frameworks supporting premium single-use device adoption shapes category positioning.
• Leading local operators lead premium format innovation.
• Organized retail and pharmacy distribution anchor branded share.

In-depth Analysis of Endotracheal Tube Market in Japan

Japan is projected to grow at a CAGR of 6.20% through 2036, reflecting aging population driving ICU admission growth, strong hospital reimbursement for premium infection-control devices, and Japanese medical device import supply chains. Nihon Kohden Corporation, Medtronic Japan, and Terumo Corporation lead the Japanese market, with Olympus and Hitachi Medical serving adjacent respiratory device categories.

• Aging population driving ICU admission growth generates consistent category demand.
• Premium positioning and convenience store distribution anchor national volumes.
• Format and packaging innovation aligns with consumer quality expectations.

Sales Analysis of Endotracheal Tube Market in China

China is expected to demonstrate above-average growth through 2036, propelled by rapid tier 2 and tier 3 hospital infrastructure expansion, rising ICU capacity under the Healthy China 2030 initiative, and domestic medical device manufacturer growth. Well Lead Medical, Shenzhen Medeke, and Medtronic China lead the domestic endotracheal tube segment, with imports from Teleflex and Smiths Medical serving tier 1 hospital procurement.

• Rapid tier 2 and tier 3 hospital infrastructure expansion generates rapid category demand growth.
• E-commerce platforms on Tmall and JD create large-scale direct consumer reach.
• Local manufacturers and foreign brands compete on quality, price, and premium positioning.

In-depth Analysis of Endotracheal Tube Market in India

India demonstrates strong growth through 2036, supported by Ayushman Bharat hospital infrastructure expansion, rising ICU capacity under the National Health Mission, and domestic medical device manufacturing growth under Make in India. Medtronic India, Teleflex India, and Smiths Medical lead premium hospital procurement, with domestic manufacturers Romsons and Sutures India serving value-tier and government procurement.

• Ayushman Bharat hospital infrastructure expansion drives organized category demand.
• Transition from unbranded suppliers to certified operators reshapes competitive dynamics.
• E-commerce and organized-retail expansion accelerate branded penetration.

Competitive Landscape and Strategic Positioning

• The top four global operators collectively hold a significant share of the endotracheal tube market, with competitive differentiation shifting from unit cost to format innovation, premium positioning, and buyer-account access.
• Regional specialists are gaining share in markets where regulatory mandates or consumer preferences favour certified, locally produced, or specialty formats.
• Startups and SMEs are carving niche positions in specialty and premium segments, targeting institutional and subscription buyer accounts.

The endotracheal tube market is shaped by integrated manufacturers and specialized category operators. Medtronic plc leads with an estimated sector-leading revenue share, built on vertically integrated manufacturing, distribution scale, and established buyer-account relationships.

Teleflex Incorporated operates global production facilities across multiple regions, specializing in format and distribution innovation. Smiths Medical supplies the category through a dedicated division focused on commercial accounts.

Becton, Dickinson and Company (BD) leverages manufacturing scale to supply commodity and specialty products across multiple end-use applications. ConvaTec Group focuses on premium and specialty formats for institutional accounts.

Barriers to entry include manufacturing capital requirements, certification under applicable safety and regulatory standards, and established supply relationships with buyer procurement organizations. Strategic priorities include developing premium formats that match commodity-tier performance, expanding certified supply coverage, and building production capacity in high-growth Asian markets.

Key Companies in Endotracheal Tube Market

Key global companies leading the endotracheal tube market include:

• Medtronic plc, Teleflex Incorporated, Smiths Medical, Becton, Dickinson and Company (BD) were identified as some of the star players in the endotracheal tube market (global), given their strong production footprint, established buyer account relationships, and product portfolio spanning commodity and premium tiers.
• ConvaTec Group, Nihon Kohden Corporation, Well Lead Medical have established strong regional positions by specializing in regional and premium formats, serving buyer accounts that prioritize certified supply, regional presence, or specialty product requirements across their respective markets.
• Venner Medical, Hospitech Respiration Ltd., Mercury Medical have distinguished themselves among startups and SMEs by securing footholds in specialized niche areas, underscoring their potential as emerging market leaders.

Competitive Benchmarking: Endotracheal Tube Market

Company	Product Breadth	Premium Tier Capability	GPO Access	Geographic Footprint
Medtronic plc	High	High	High	Global
Teleflex Incorporated	High	High	High	Global
Smiths Medical	High	High	High	Global
Becton, Dickinson and Company	High	Medium	High	Global
ConvaTec Group	Medium	Medium	Medium	Europe, Global
Nihon Kohden Corporation	Medium	Medium	Medium	Asia-Pacific
Well Lead Medical	Medium	Low	Medium	Asia-Pacific
Venner Medical	Low	Medium	Low	Europe
Hospitech Respiration Ltd.	Low	High	Low	Europe, Middle East
Mercury Medical	Medium	Medium	Medium	North America

Source: Future Market Insights competitive analysis, 2026.

Key Developments in Endotracheal Tube Market

• In 2025, Medtronic expanded its Shiley endotracheal tube portfolio in the United States and Europe with new subglottic suction port configurations targeting hospital VAP prevention program procurement.
• In 2025, Teleflex Incorporated launched a new silicone endotracheal tube line with antimicrobial coating technology for ICU and operating room use, positioned for premium hospital GPO contracts.

Key Players in the Endotracheal Tube Market:

Major Global Players:

• Medtronic plc
• Teleflex Incorporated
• Smiths Medical
• Becton, Dickinson and Company (BD)
• ConvaTec Group
• Nihon Kohden Corporation
• Well Lead Medical

Emerging Players/Startups

• Venner Medical
• Hospitech Respiration Ltd.
• Mercury Medical

Scope of the report

Metric	Value
Quantitative Units	USD 2.79 billion to USD 5.14 billion, at a CAGR of 6.3%
Market Definition	The endotracheal tube market covers single-use and reusable endotracheal tubes including regular.
Regions Covered	North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries Covered	India, China, USA, UK, Germany, Japan, South Korea, Brazil, 30 plus countries
Key Companies Profiled	Medtronic plc, Teleflex Incorporated, Smiths Medical, Becton, Dickinson and Company (BD), ConvaTec Group, Nihon Kohden Corporation, Well Lead Medical, Venner Medical, Hospitech Respiration Ltd., Mercury Medical
Forecast Period	2026 to 2036
Approach	Hybrid bottom-up and top-down methodology starting with verified endotracheal tube transaction data, projecting adoption velocity across segments and regions.

Market Segmentation Analysis

Endotracheal Tube Market Market Segmented by Product Type:

• Regular Endotracheal Tube
• Reinforced Endotracheal Tube
• Preformed Endotracheal Tube
• Double Lumen Endotracheal Tube

Endotracheal Tube Market Market Segmented by Route Type:

• Orotracheal
• Nasotracheal

Endotracheal Tube Market Market Segmented by Application:

• Emergency Treatment
  • Rapid Sequence Intubation
  • Trauma Care
• Therapy
  • Mechanical Ventilation
  • Anesthesia Support
• Other Applications
  • Neonatal Care

Endotracheal Tube Market Market Segmented by End-use:

• Hospitals
  • Intensive Care Units
  • Emergency Departments
• Clinics
  • Specialty Clinics
• Ambulatory Surgical Centres
  • Day Care Procedures
• Other End Uses

Endotracheal Tube Market Market Segmented by Material:

• Polyvinyl Chloride
  • Standard Grade PVC
  • Medical Grade PVC
• Silicone
  • Reusable Silicone
• Thermoplastic Elastomer
  • Flexible Elastomer
• Others

Endotracheal Tube Market Market Segmented by Distribution Channel:

• Direct Sales to Hospitals
  • Bulk Procurement Contracts
• Medical Device Distributors
  • Regional Distributors
• Online Medical Supply Platforms
  • E-Commerce Healthcare Platforms

Endotracheal Tube Market Market by Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa

Research Sources and Bibliography

• 1. World Health Organization. (2024). Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia Prevention Guidelines. WHO.
• 2. USA Centers for Disease Control and Prevention. (2024). Healthcare-Associated Infections: Ventilator-Associated Events Surveillance Report. CDC.
• 3. American Association for Respiratory Care. (2024). Clinical Practice Guidelines for Mechanical Ventilation. AARC.
• 4. European Centre for Disease Prevention and Control. (2024). Point Prevalence Survey of Healthcare-Associated Infections. ECDC.
• 5. International Organization for Standardization. (2023). ISO 5361 Anaesthetic and Respiratory Equipment: Tracheal Tubes and Connectors. ISO.

This bibliography is provided for reader reference

This Report Answers

• Market sizing and revenue forecasting for endotracheal tube products from 2026 to 2036.
• Segmentation analysis across product type, route type, application, end use, and region.
• Regional and country-level insights covering over 30 markets with comparative growth analysis.
• Regulatory analysis covering industry-relevant directives, safety and labeling rules, and regional compliance frameworks.
• Competitive landscape assessment covering market structure, vendor positioning, and recent developments.
• Investment opportunity mapping across the critical care medical devices and respiratory care sector.
• Supply chain tracking from raw material sourcing to finished product distribution and end-use delivery.
• Data delivery in PDF and Excel formats with quarterly refresh access.